Nowik Christina M, Davies Gregory A L, Smith Graeme N
Department of Obstetrics and Gynaecology, Kingston General Hospital, Kingston ON.
J Obstet Gynaecol Can. 2017 Jan;39(1):49-51. doi: 10.1016/j.jogc.2016.05.011. Epub 2016 Dec 10.
The Society for Maternal-Fetal Medicine recently released a statement supporting the use of antenatal corticosteroids for women at high risk of late preterm birth. This followed a trend of increasing use of antenatal corticosteroids after 34 weeks' gestation, based on evidence for decreased respiratory morbidity. The absolute benefits, however, are relatively small. We should balance this against the possible long-term harms of corticosteroids after 34 weeks before expanding the indications for their antenatal use.
母胎医学会最近发布了一份声明，支持对晚期早产高危女性使用产前糖皮质激素。这是基于34周妊娠后呼吸疾病发病率降低的证据，使用产前糖皮质激素的趋势不断增加之后的举措。然而，绝对益处相对较小。在扩大其产前使用指征之前，我们应权衡这一点与34周后糖皮质激素可能带来的长期危害。
